$4.47
0.45% today
Nasdaq, Oct 02, 10:00 pm CET
ISIN
CH1125843347
Symbol
SOPH

SOPHiA Genetics SA Stock price

$4.45
+0.99 28.61% 1M
+1.28 40.38% 6M
+1.38 44.95% YTD
+0.85 23.61% 1Y
+1.83 69.85% 3Y
-12.31 73.45% 5Y
-12.31 73.45% 10Y
-12.31 73.45% 20Y
Nasdaq, Closing price Wed, Oct 01 2025
-0.31 6.51%
ISIN
CH1125843347
Symbol
SOPH

Key metrics

Basic
Market capitalization
$300.7m
Enterprise Value
-
Net debt
-
Cash
-
Shares outstanding
-
Valuation (TTM | estimate)
P/E
negative | negative
P/S
4.3 | 4.0
EV/Sales
- | -
EV/FCF
-
P/B
-
Financial Health
Equity Ratio
62.1%
Return on Equity
-64.8%
ROCE
-
ROIC
-
Debt/Equity
-
Financials (TTM | estimate)
Revenue
$69.7m | $76.0m
EBITDA
$-58.2m | $-40.2m
EBIT
$-67.3m | $-67.6m
Net Income
$-73.4m | -
Free Cash Flow
$-45.7m
Growth (TTM | estimate)
Revenue
7.3% | 16.6%
EBITDA
4.6% | 30.7%
EBIT
2.8% | -1.6%
Net Income
-9.9% | -
Free Cash Flow
17.8%
Margin (TTM | estimate)
Gross
67.8%
EBITDA
-83.5% | -52.9%
EBIT
-96.6%
Net
-105.3% | -
Free Cash Flow
-65.5%
More
EPS
$-1.1
FCF per Share
-
Short interest
0.1%
Employees
423
Rev per Employee
$150.0k
Show more

Is SOPHiA Genetics SA a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,001 stocks worldwide.

SOPHiA Genetics SA Stock Analysis

Unlock Scores for Free

Analyst Opinions

11 Analysts have issued a SOPHiA Genetics SA forecast:

10x Buy
91%
1x Hold
9%

Analyst Opinions

11 Analysts have issued a SOPHiA Genetics SA forecast:

Buy
91%
Hold
9%

Financial data from SOPHiA Genetics SA

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
70 70
7% 7%
100%
- Direct Costs 22 22
9% 9%
32%
47 47
6% 6%
68%
- Selling and Administrative Expenses 80 80
2% 2%
115%
- Research and Development Expense 35 35
4% 4%
50%
-58 -58
5% 5%
-83%
- Depreciation and Amortization 9.17 9.17
11% 11%
13%
EBIT (Operating Income) EBIT -67 -67
3% 3%
-97%
Net Profit -73 -73
10% 10%
-105%

In millions USD.

Don't miss a Thing! We will send you all news about SOPHiA Genetics SA directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

SOPHiA Genetics SA Stock News

Neutral
PRNewsWire
9 days ago
SALT LAKE CITY and BOSTON , Sept. 23, 2025 /PRNewswire/ -- Myriad Genetics (Nasdaq: MYGN), a leader in molecular diagnostic testing and precision medicine, and SOPHiA GENETICS (Nasdaq: SOPH), an AI technology company transforming precision medicine, announced a strategic collaboration to develop and provide pharmaceutical companies with an innovative global liquid biopsy companion diagnostic (C...
Neutral
GlobeNewsWire
9 days ago
SALT LAKE CITY and BOSTON, Sept. 23, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics (Nasdaq: MYGN), a leader in molecular diagnostic testing and precision medicine, and SOPHiA GENETICS (Nasdaq: SOPH), an AI technology company transforming precision medicine, announced a strategic collaboration to develop and provide pharmaceutical companies with an innovative global liquid biopsy companion diagnostic...
Neutral
PRNewsWire
10 days ago
BOSTON , Sept. 22, 2025 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), an AI technology company transforming precision medicine, today announced an expansion of its collaboration with AstraZeneca (LSE/STO/Nasdaq: AZN) from the World CB & CDx Summit in Boston.
More SOPHiA Genetics SA News

Company Profile

SOPHiA GENETICS SA is a healthcare technology company, which establishes the practice of data driven medicine as the standard of care and for life sciences research. It is the creator of the SOPHiA DDM Platform, a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The company was founded by Jurgi Camblong, Pierre Hutter and Lars Steinmetz in 2011 and is headquartered in Saint Sulpice, Switzerland.

Head office Switzerland
CEO Jurgi Camblong
Employees 423
Founded 2011
Website www.sophiagenetics.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today